| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:2379.)
© 2005 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
| Abstract |
|---|
|
|
|---|
Methods This retrospective study examined data from acute ischemic stroke patients who underwent diffusion-weighted imaging, GRE and magnetic resonance angiography (MRA) within 24 hours of stroke onset and who had symptomatic occlusion of large intracranial arteries in the circle of Willis. Hypointense signals within vascular cisterns on GRE corresponding to symptomatic vascular occlusion were termed "GRE SVS." Recanalization was assessed on follow-up MRA performed within 7 days of onset. The relationships between GRE SVS and stroke subtypes and subsequent recanalization were explored.
Results Of the 95 patients who met the inclusion criteria, GRE SVS was observed in 45 (47.4%). GRE SVS was more commonly associated with cardioembolic stroke patients (31 of 40, 77.5%) than with other stroke subtypes (14 of 55, 25.5%; P<0.001). In 66 patients who underwent follow-up MRA, GRE SVS was associated with subsequent recanalization (P<0.001). Multivariate analysis showed that GRE SVS was an independent predictor of cardioembolic stroke and subsequent recanalization (odds ratio, 10.75 and 4.26; 95% CI, 3.68 to 31.47 and 1.12 to 16.30).
Conclusions GRE SVS may predict cardioembolic stroke and subsequent recanalization. Identifying clot composition may be important in choosing the optimal treatment based on clot characteristics.
Key Words: diagnosis magnetic resonance imaging stroke, acute ischemic stroke subtype
| Introduction |
|---|
|
|
|---|
Blood goes through sequential stages of degradation from oxyhemoglobin to deoxyhemoglobin, methemoglobin, and then hemosiderin, which can each be identified using MRI. In contrast to oxyhemoglobin, the presence of unpaired electrons in deoxyhemoglobin, methemoglobin, and hemosiderin gives them paramagnetic properties, which produce an inhomogeneity in magnetic fields.4 This property of paramagnetic molecules is termed the magnetic susceptibility effect and causes signal loss on MRI, which is best detected using T2*-weighted gradient echo imaging (GRE).5
Intraluminal clots evolve in stages similar to parenchymal hematomas.4 Thus, red thrombi in occlusive vessels may be seen as hypointense signals within vascular cisterns on GRE because of the paramagnetic property of deoxygenated hemoglobin components in trapped red blood cells. We termed this radiological finding the "GRE susceptibility vessel sign (GRE SVS)".6 In the present study, we tested the hypothesis that the presence of GRE SVS may predict cardioembolic stroke. We also sought to determine whether GRE SVS is associated with subsequent recanalization.
| Materials and Methods |
|---|
|
|
|---|
Imaging Analysis
MRI examinations were performed using a 1.5-T MR imaging unit (Signa; GE Medical Systems, Milwaukee, WI) with echo-planar capabilities. Included in the protocol for this study were DWI, GRE, 3D time-of-flight MRA, and 3D contrast-enhanced MRA. The common MRI parameters for DWI and GRE were a slice thickness of 5 mm, an interslice gap of 2 mm, 20 axial slices, and a field-of-view of 250 mm. DWI parameters included a repetition time (TR) of 7500 ms, an echo time (TE) of 84 ms, a matrix number of 128x128, and two b values of 0 and 1000 s/mm2. GRE parameters were a TR of 400 ms, a TE of 30 ms, a flip angle of 20°, and a matrix number of 256x192. Common MRA parameters included a flip angle of 20°, a matrix number of 512x512, and a field-of-view of 250 mm. A 3D time-of-flight MRA of the circle of Willis was performed with a TR of 25 ms and TE of 2 ms. A 3D contrast-enhanced MRA from the aortic arch to the level of the central skull base was obtained using an IV bolus injection of 20 mL (3 to 4 mL/s) gadopentetate dimeglumine (Magnevist; Schering, Berlin, Germany) with a TR of 6 ms and TE of 1 ms.
GRE interpretations were performed by an investigator (D-W.K.) blinded to clinical data and other magnetic resonance sequences other than information regarding the side of the index lesion. GRE SVS was defined as a hypointense signal on GRE within vascular cisterns in corresponding symptomatic occlusive vessels. The diameter of the hypointense signals should exceed the contralateral vessel diameter.7,8 Acute and follow-up MRA data were independently reviewed in different sessions. Significant recanalization was defined if follow-up MRA revealed complete visualization of branch arteries distal to occluded vessels with residual stenosis <50%.
Clinical Assessments
Clinical data were obtained by reviewing stroke registry and medical records. In addition to MRI studies, the following investigations were performed in all of the patients: complete blood count, erythrocyte sedimentation rate, chemistry, serology, coagulation tests, ECG, chest x-rays, and urinalysis. Transthoracic and transesophageal echocardiography and 24-hour ECG monitoring were performed in the following patients: (1) those with history of heart disease, irregular pulse on physical examination, clinical or radiological cardiac abnormalities, or rhythm abnormalities on ECG; (2) those who were young (<45 years) and without atherosclerosis risk factors; (3) those with suspected infective endocarditis or marantic endocarditis; or (4) those whose MRA did not indicate an extracardiac source of stroke. Stroke subtypes were determined according to the classification of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).9 TOAST diagnosis was made by 3 stroke neurologists (J.S.K., S.U.K., and D.-W.K.) blinded to the GRE findings, and discrepancies were settled by consensus discussion.
Data Analysis
First, we tested the association of GRE SVS with stroke subtypes and subsequent recanalization. Then we explored whether GRE SVS predicts cardioembolic stroke and recanalization independent of demographics, risk factors, admission NIHSS score, time to MRI scan from onset, site of vessel occlusion, and thrombolytic treatment (Table 1). For univariate analysis, Pearson
2 test using the exact method, Student t test, or the Mann-Whitney test were applied where appropriate. Multiple logistic regression analysis was performed to estimate the independent contributions of variables to dependent variables (ie, cardioembolism and recanalization). Variables were selected for entry into the model based on the results of univariate analysis (P
0.1). The odds ratio and 95% CI were obtained. The Hosmer-Lemeshow goodness-of-fit test was used to assess how well the model accounted for outcomes. SPSS for Windows (version 11.5, SPSS Inc) was used for statistical analysis. A 2-tailed P value of <0.05 was considered to indicate a significant difference.
|
| Results |
|---|
|
|
|---|
Symptomatic occluded vessels were middle cerebral artery (MCA) stem in 46 patients, MCA branch in 19, distal internal carotid artery in 15, posterior cerebral artery in 14, and anterior cerebral artery in 1. GRE SVS was identified in 45.7% of patients (21 of 46) with MCA stem occlusion, 73.7% (14 of 19) of those with MCA branch occlusion, 26.7% (4 of 15) of those with distal internal carotid artery occlusion, 42.9% (6 of 14) of those with posterior cerebral artery occlusion, and 0% (0 of 1) of those with anterior cerebral artery occlusion (P=0.063). Demographics, risk factors, and admission NIHSS score were not different between patients with and without GRE SVS.
Association Between GRE SVS and Stroke Subtypes
GRE SVS was identified in 45 (47.4%) of the total 95 patients. GRE SVS was significantly associated with cardioembolic stroke. Of the 40 cardioembolic stroke patients, 31 (77.5%) had GRE SVS, whereas for the 55 patients with other stroke subtypes, only 14 (25.5%) had GRE SVS (P<0.001, Figure 1). Among these 14 patients, 6 had intracranial large artery atherosclerosis (LAA), 1 had extracranial LAA, and the remaining 7 had cryptogenic etiology.
|
Current smoking (P=0.058), time-to-initial MRI (P=0.076), and site of occlusion (P=0.062) were also marginally associated with cardioembolic stroke (Table 1). In multiple logistic regression analysis, GRE SVS and absence of current smoking independently predicted cardioembolic stroke (Table 2).
|
Association Between GRE SVS and Subsequent Recanalization
In a subgroup of 66 patients who underwent follow-up MRA, 30 (45.5%) demonstrated significant recanalization, and 29 (43.9%) showed GRE SVS. Among all of the clinical and radiological variables, cardioembolic stroke (P<0.001), GRE SVS (P<0.001), time-to-initial MRI (P=0.01), site of vessel occlusion (P=0.093), and thrombolytic treatment (P=0.052) were associated with subsequent recanalization, with P
0.1 according to univariate analysis (Table 1). Of the 30 patients who showed recanalization, 21 (70%) had GRE SVS (see Figure 2 for example). In multiple logistic regression analysis, cardioembolic stroke and GRE SVS were independent predictors of subsequent recanalization (Table 2).
|
| Discussion |
|---|
|
|
|---|
This study also showed that GRE SVS was associated with subsequent recanalization, independent of other clinical and radiological characteristics. Although the natural course of spontaneous recanalization according to stroke subtypes is understudied, cardioembolic occlusion has been shown to more frequently recanalize than other stroke subtypes. A recent study evaluated the sonographic patterns of clot lysis during tPA infusion among stroke subtypes and found that vessel recanalization was more frequent and more complete in patients with cardioembolic stroke.15 Given the high-binding affinity of tPA for fibrin, tPA may penetrate and distribute homogeneously, leading to effective dissolution of emboli from the heart, which is characterized by more uniform fibrin-rich clots. Now our results provide evidence of a link among GRE SVS, cardioembolic stroke, and subsequent recanalization.
Identification of GRE SVS may help guide therapeutic decisions in terms of indicating whether an occlusive clot is susceptible or resistant to fibrinolytic therapy.13,14 In acute coronary syndrome, obstructive arterial thrombi that are platelet rich are resistant to thrombolysis and have an increased tendency to reocclude after initial reperfusion.16 In these circumstances, an antiplatelet agent used in combination with a thrombolytic agent not only offers the potential for enhancing thrombolysis and reducing the risk of reocclusion but also permits this to be accomplished with reduced doses of thrombolytics and heparin.17 Therapeutic decisions with regard to clot composition may facilitate thrombolysis and reperfusion. In addition, in acute stroke syndrome, from a mechanistic perspective, it may be that vessel occlusion with GRE SVS is more sensitive to fibrinolytic therapy, although the results of such investigations are not yet conclusive.6 The present study did not investigate the relationship between different thrombolytic response patterns and GRE SVS because of the limited number of patients who received thrombolysis. Future studies using a larger sample size are required to explore this issue.
Of the 40 cardioembolic stroke patients in this study, we could not identify GRE SVS in 9 patients. It is likely that small-sized red thrombi might have been missed because of the GRE interslice gap, because GRE SVS was diagnosed if the hypointense signals exceeded the contralateral vessel diameter. Clot age and hemoglobin oxidation state may also explain these findings. Hemoglobin desaturation from oxyhemoglobin to deoxyhemoglobin occurs within a few hours. Thus, in hyperacute clot cases, the main component may still be oxyhemoglobin, which does not produce a magnetic susceptibility effect. If oxyhemoglobin had not sufficiently degraded to deoxyhemoglobin, hyperacute clots would not have been identified as hypointense signals on GRE.
Fourteen patients with GRE SVS were eventually classified as having stroke etiology other than cardioembolism. Seven of the 44 LAA patients had GRE SVS. We suggest that this is probably attributable to the process of clot formation, which occurs similarly in coronary vessels. White thrombi initially form as the result of deep fissuring of atherosclerotic plaques or extensive endothelial erosion. This initial intraplaque thrombus, which is composed predominantly of platelets, leads to a local reduction in blood flow and additional thrombosis within the arterial lumen. Ultimately, completely occlusive thrombi consist of a fibrin network with numerous enmeshed red blood cells superimposed on the underlying platelet-rich clot.3 Our results also support this idea, because 6 of the 7 LAA patients with GRE SVS had intrinsic intracranial arterial disease.
Seven of the 9 patients with cryptogenic stroke etiology also showed GRE SVS. Based on our pathway for stroke etiology work-up, 6 of these patients were not completely evaluated for cardiogenic causes. In these patients, occult unidentified cardioembolic sources might have been present. Thus, it may be reasonable to initiate detailed cardiac evaluation in patients with GRE SVS, even if cardiac abnormalities are not suspected.
This study has several limitations. Although our stroke center has a clinical pathway for diagnosis and management of stroke patients, the investigative work-ups for stroke etiology were not identical in all of the patients. Echocardiography and follow-up MRA were not performed on all of the patients. The choice of MRA as a reference for vessel occlusion and recanalization is less accurate than catheter angiography. Our study is more heterogeneous with regard to the time window from onset compared with previous studies,6,7 although the sample size is larger. Long-term follow-up data for assessing the prognostic value of GRE SVS are lacking in the present study.
In conclusion, the present study indicates that GRE SVS may predict cardioembolic stroke and subsequent recanalization. Identifying thrombi composition may be important in choosing the optimal treatment based on clot characteristics.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received July 7, 2005; accepted July 20, 2005.
| References |
|---|
|
|
|---|
Related Article:
This article has been cited by other articles:
![]() |
E. Doufekias, A. Z. Segal, and J. R. Kizer Cardiogenic and aortogenic brain embolism. J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1049 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Leach, W.M. Strub, and M.F. Gaskill-Shipley Cerebral Venous Thrombus Signal Intensity and Susceptibility Effects on Gradient Recalled-Echo MR Imaging AJNR Am. J. Neuroradiol., May 1, 2007; 28(5): 940 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-W. Kang, S. U. Kwon, S.-H. Yoo, K.-Y. Kwon, C. G. Choi, S. J. Kim, J.-Y. Koh, and J. S. Kim Early Recurrent Ischemic Lesions on Diffusion-Weighted Imaging in Symptomatic Intracranial Atherosclerosis Arch Neurol, January 1, 2007; 64(1): 50 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Molina Imaging the Clot: Does Clot Appearance Predict the Efficacy of Thrombolysis? Stroke, November 1, 2005; 36(11): 2333 - 2334. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |